Jorge Dunstan

946 total citations
17 papers, 163 citations indexed

About

Jorge Dunstan is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Jorge Dunstan has authored 17 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Dermatology. Recurrent topics in Jorge Dunstan's work include Cutaneous Melanoma Detection and Management (5 papers), Breast Lesions and Carcinomas (3 papers) and BRCA gene mutations in cancer (3 papers). Jorge Dunstan is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), Breast Lesions and Carcinomas (3 papers) and BRCA gene mutations in cancer (3 papers). Jorge Dunstan collaborates with scholars based in Peru, United States and Mexico. Jorge Dunstan's co-authors include Carlos A. Castañeda, Miluska Castillo, Henry Gómez, Julio E. Abugattas, Gabriela Calderón, Miguel De la Cruz, José M. Cotrina, Joselyn Sanchez, Sandro Casavilca‐Zambrano and Henry Miller and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jorge Dunstan

14 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Dunstan Peru 7 132 44 33 31 27 17 163
Fernando Henao Spain 7 121 0.9× 67 1.5× 31 0.9× 37 1.2× 18 0.7× 24 198
Judith Sirokay Germany 6 83 0.6× 50 1.1× 16 0.5× 68 2.2× 26 1.0× 9 164
Jennifer Keller United States 6 142 1.1× 32 0.7× 27 0.8× 80 2.6× 45 1.7× 18 186
Elena Giudice Italy 8 134 1.0× 29 0.7× 38 1.2× 93 3.0× 18 0.7× 33 240
Ruohong Shui China 5 84 0.6× 30 0.7× 31 0.9× 17 0.5× 20 0.7× 13 119
Dalia Alqunaibit United States 4 125 0.9× 101 2.3× 14 0.4× 25 0.8× 9 0.3× 7 181
Takashi Mineo Japan 4 85 0.6× 43 1.0× 30 0.9× 37 1.2× 24 0.9× 12 168
Iris Wang United States 6 100 0.8× 59 1.3× 19 0.6× 23 0.7× 6 0.2× 13 148
Edoardo Biondi Italy 6 80 0.6× 21 0.5× 14 0.4× 18 0.6× 63 2.3× 14 188
Aleigha Lawless United States 4 179 1.4× 43 1.0× 13 0.4× 48 1.5× 19 0.7× 21 218

Countries citing papers authored by Jorge Dunstan

Since Specialization
Citations

This map shows the geographic impact of Jorge Dunstan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Dunstan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Dunstan more than expected).

Fields of papers citing papers by Jorge Dunstan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Dunstan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Dunstan. The network helps show where Jorge Dunstan may publish in the future.

Co-authorship network of co-authors of Jorge Dunstan

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Dunstan. A scholar is included among the top collaborators of Jorge Dunstan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Dunstan. Jorge Dunstan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ku, Gabriel De la Cruz, et al.. (2024). Unveiling Melanoma: A Deep Dive into Disparities at a Latin-American Cancer Institute. Annals of Surgical Oncology. 31(9). 6097–6117.
2.
Ku, Gabriel De la Cruz, et al.. (2024). ASO Visual Abstract: Unveiling Melanoma—A Deep Dive Into Disparities at a Latin-American Cancer Institute. Annals of Surgical Oncology. 31(9). 6123–6124.
3.
Calderón, Gabriela, Carlos A. Castañeda, Miluska Castillo, et al.. (2022). Human Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Women. Asian Pacific Journal of Cancer Prevention. 23(5). 1571–1576. 8 indexed citations
4.
Castañeda, Carlos A., Miluska Castillo, Joselyn Sanchez, et al.. (2021). A biomarker study in Peruvian males with breast cancer. World Journal of Clinical Oncology. 12(10). 926–934. 1 indexed citations
5.
Bain, Carolyn, Pooja Bansil, Sílvia de Sanjosé, et al.. (2021). Evaluation of diagnostic ultrasound use in a breast cancer detection strategy in Northern Peru. PLoS ONE. 16(6). e0252902–e0252902. 9 indexed citations
6.
Matsumoto, Monica M., Tatiana Vidaurre, Jorge Dunstan, et al.. (2020). Earlier Breast Cancer Detection in Peru: Establishing a Comprehensive Program in an Underserved Region. Journal of the American College of Radiology. 17(11). 1520–1524. 5 indexed citations
7.
Castañeda, Carlos A., Miluska Castillo, Carlos A. Torres‐Cabala, et al.. (2019). Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma. Clinical & Translational Oncology. 21(9). 1127–1134. 18 indexed citations
8.
Castañeda, Carlos A., Miluska Castillo, Henry Gómez, et al.. (2018). Critical review of axillary recurrence in early breast cancer. Critical Reviews in Oncology/Hematology. 129. 146–152. 10 indexed citations
9.
Castañeda, Carlos A., Joselyn Sanchez, Miluska Castillo, et al.. (2018). Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy. World Journal of Clinical Oncology. 9(2). 33–41. 23 indexed citations
10.
Castañeda, Carlos A., Miluska Castillo, Joselyn Sanchez, et al.. (2018). Androgen Expression & Clinicopathological Features in Male Breast Cancer. SHILAP Revista de lepidopterología. 7(1). 2 indexed citations
11.
Castañeda, Carlos A., Miluska Castillo, Cynthia Villarreal‐Garza, et al.. (2018). Genetics, Tumor Features and Treatment Response of Breast Cancer in Latinas. SHILAP Revista de lepidopterología. 7(1). 1 indexed citations
12.
Castañeda, Carlos A., Carlos A. Torres‐Cabala, Miluska Castillo, et al.. (2017). Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America. Clinical & Translational Oncology. 19(12). 1478–1488. 41 indexed citations
13.
Castañeda, Carlos A., Elizabeth A. Mittendorf, Sandro Casavilca‐Zambrano, et al.. (2016). Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy. World Journal of Clinical Oncology. 7(5). 387–387. 39 indexed citations
14.
Sarria, Gustavo R., et al.. (2016). Acelerando la innovación en el control del cáncer en el Perú. Revista Peruana de Medicina Experimental y Salud Pública. 33(3). 535–535.
15.
Morante, Zaida, et al.. (2016). Outcomes and prognostic factors for acral lentiginous melanoma in Peruvian patients.. Journal of Clinical Oncology. 34(15_suppl). e21061–e21061. 1 indexed citations
16.
Dunstan, Jorge, Carlos A. Castañeda, Julio E. Abugattas, et al.. (2015). Sentinel Lymph Node Biopsy and Axillary Dissection in Breast Cancer: Results in a Latina Population. 4(6). 295–302. 1 indexed citations
17.
Ferner, R E, et al.. (1989). DRUGS IN DONATED BLOOD. The Lancet. 334(8654). 93–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026